Zdrowie i gospodarka · 23.05.2001
Guidance for Industry on Bioanalytical Method Validation; Availability
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Bioanalytical Method Validation." This guidance provides assistance to sponsors of investigational new drug applications (INDs), new drug applications (NDAs), abbreviated new drug applications (ANDAs), and their supplements in developing validation information on bioanalytical methods for pharmacokinetic (PK) evaluation of human clinical pharmacology, bioavailability (BA), and bioequivalence (BE) studies. The guidance also applies to bioanalytical methods used for nonhuman pharmacology/toxicology studies and preclinical studies. For studies related to the veterinary drug approval process, this guidance applies only to blood and urine BA, BE, and PK studies.